Patent details
EP2773205
Title:
RIFAXIMIN FOR RETREATING DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
Basic Information
- Publication number:
- EP2773205
- PCT Application Number:
- US2012063380
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP128447679
- PCT Publication Number:
- WO2013067394
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RIFAXIMIN FOR RETREATING DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
- French Title of Invention:
- RIFAXIMINE POUR LE TRAITEMENT DU SYNDROME DU CÔLON IRRITABLE AVEC DIARRHÉE
- German Title of Invention:
- RIFAXIMIN ZUR BEHANDLUNG VON DURCHFALL-REIZDARMSYNDROM
- SPC Number:
-
Dates
- Filing date:
- 02/11/2012
- Grant date:
- 22/05/2024
- EP Publication Date:
- 10/09/2014
- PCT Publication Date:
- 10/05/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/05/2024
- EP B1 Publication Date:
- 22/05/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 02/11/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/05/2024
-
-
- Name:
- Salix Pharmaceuticals, Inc.
- Address:
- 8450 Colonnade Center Drive, Colonnade 1, Raleigh, NC 27615, United States (US)
Agent
- Name:
- NOVAGRAAF BREVETS
- From:
- 24/06/2024
- Address:
- BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
- To:
Inventor
1
- Name:
- FORBES, William
- Address:
- United States (US)
2
- Name:
- MERCHANT, Kunal
- Address:
- United States (US)
3
- Name:
- BORTEY, Enoch
- Address:
- United States (US)
4
- Name:
- GOLDEN, Pam
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201161554662 P
- Priority Date:
- 02/11/2011
- Priority Country:
- United States (US)
2
- Priority Number:
- 201161559686 P
- Priority Date:
- 14/11/2011
- Priority Country:
- United States (US)
3
- Priority Number:
- 201161560133 P
- Priority Date:
- 15/11/2011
- Priority Country:
- United States (US)
4
- Priority Number:
- 201161560267 P
- Priority Date:
- 15/11/2011
- Priority Country:
- United States (US)
5
- Priority Number:
- 201161560128 P
- Priority Date:
- 15/11/2011
- Priority Country:
- United States (US)
6
- Priority Number:
- 201161560273 P
- Priority Date:
- 15/11/2011
- Priority Country:
- United States (US)
7
- Priority Number:
- 201161560788 P
- Priority Date:
- 16/11/2011
- Priority Country:
- United States (US)
8
- Priority Number:
- 201161563033 P
- Priority Date:
- 22/11/2011
- Priority Country:
- United States (US)
9
- Priority Number:
- 201161564270 P
- Priority Date:
- 28/11/2011
- Priority Country:
- United States (US)
10
- Priority Number:
- 201261600635 P
- Priority Date:
- 18/02/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/437;
A61K 31/545;
A61P 1/08;
A61P 1/10;
A61P 1/14;
A61P 7/00;
A61P 11/00;
A61P 13/02;
A61P 29/00;
A61P 31/04;
A61P 39/02;
A61P 43/00;
A61P 1/00;
A61P 13/12;
Publication
European Patent Bulletin
- Issue number:
- 202421
- Publication date:
- 22/05/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 01/12/2025
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 25/10/2024
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM